Smart people are smart. Fast techniques are fast. Smart people with fast techniques is what you are looking for in situations like the one COVID-19 set us in.
Seo [Jung-Jin, Celltrion Chairman] said Celltrion has completed what it considers the “most difficult part” of the process, the construction of a 300-antibody library from blood samples collected from recovered patients.
According to Seo, Celltrion aims to develop a super antibody that will be able to “perfectly adapt to any mutations.” When asked how, he explained: “There is an average lag time of three months between the mutation and the production of a product that has adapted to the mutation. And we will adapt the product to the mutation within those three months.”